WO2015002625A1 - The occluder device for cardiovascular system - Google Patents

The occluder device for cardiovascular system Download PDF

Info

Publication number
WO2015002625A1
WO2015002625A1 PCT/TR2014/000234 TR2014000234W WO2015002625A1 WO 2015002625 A1 WO2015002625 A1 WO 2015002625A1 TR 2014000234 W TR2014000234 W TR 2014000234W WO 2015002625 A1 WO2015002625 A1 WO 2015002625A1
Authority
WO
WIPO (PCT)
Prior art keywords
mentioned
occluder
occluder device
retention zone
heart
Prior art date
Application number
PCT/TR2014/000234
Other languages
French (fr)
Inventor
Oran BULENT
Original Assignee
Bulent Oran
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bulent Oran filed Critical Bulent Oran
Publication of WO2015002625A1 publication Critical patent/WO2015002625A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12122—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder within the heart
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12177—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238—Type of minimally invasive operation
    • A61B2017/00243—Type of minimally invasive operation cardiac
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00526—Methods of manufacturing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00592—Elastic or resilient implements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00597—Implements comprising a membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00606—Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00623—Introducing or retrieving devices therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00632—Occluding a cavity, i.e. closing a blind opening
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831—Material properties
    • A61B2017/00867—Material properties shape memory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205—Introduction devices
    • A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device

Definitions

  • the invention is related to the "occluder device" for cardiovascular system and its production process.
  • the occluder device is self-expanding, comprising of braided wire mesh made of a memory material similar to nitinol (nickel-titanium), alloy or metal, thread mesh, natural or artificial matrix.
  • the exterior of the braided wire mesh has been coated with biocompatible material such as gold through various technological methods in order to prevent the secretion and releasing of nickel into the tissues in time, which may be harmful to the human body.
  • the final shape of the device with a hollow design is formed with heat treatment process, and it gains self- expandability.
  • the device consists of an expandable body part which occludes with a partly hollow holder.
  • the body part consists of the proximal retention zone, neck and distal retention zone parts and it is placed in the patients with its specific carrier apparatus.
  • lumen occlusion devices in different shapes and structures have been used since the past. These devices can be placed by transcatheter methods which require no surgical intervention. Especially in the last ten years, we can see the rapid development in this area.
  • the most common types have been manufactured from nitinol like metal alloy wires known as memory metal.
  • Such devices include a releasable connection apparatus after it has been inserted into appropriate places via the catheter. Also it has a carrier system such that the device can be pulled back into the sheath if the location is not suitable and then can be taken out again.
  • One of the first examples is the "Amplatzer” branded occluder device of Aga Medical Corporation, and it had two separate welding points; one in the front and one at the back of the lumen occluder device, and all the wires made of nitinol alloy, which establishes the system, were connected together by these two points welding.
  • the "Occlutech” branded occluder device that belongs to Occlutech Holding AG was available at the market. Although this device was made of wires with the same alloy and similar design, all the wires were attached together with only one point welding. Thus a lighter device was obtained with only one point welding, and when compared with the other devices, it is stated that less metal load has been imposed to the human body.
  • the shape of the device or connection apparatus were modified but nitinol, a memory metal, was used in all of them. Screw was used as a connector apparatus in the first twos, and different mechanical apparatus were proposed for the devices developed later.
  • the hole in interatrial septum between the two atria of the heart is called “atrial septal defect” and if it is too small, it is called “patent foramen ovale”.
  • the hole in the interventricular septum between the two ventricles of the heart is known as “ventricular septal defect”.
  • mitent ductus arteriosus is another defect to be occluded.
  • occluder device for left atrial appendage is placed. Thus, surgical intervention of a cardiac surgeon is no longer required for the closure of such defects.
  • Lumen occlusion devices in different shapes and structures are placed by transcatheter methods and occlusion is achieved through the sheath positioned in the groin artery and conveying systems.
  • Occlusion devices known as memory metal wires are made from metal alloys like nitinol.
  • the shape or connection apparatus have been modified in all of the devices but nitinol, which is a memory metal, is still used. Screws are used as the connection apparatus in some devices, but various mechanical apparatus have been proposed in the devices developed later.
  • our invention is one of the lightest metal load occluder devices that have ever been developed, and that is, although the proximal retention zone forms a disc-shaped body, the center of distal retention area is open. It has been designed like basket and looks as if it is an outspread hem of a whirling dervish's skirt, and thus, it has formed a lighter structure than its counterparts.
  • Employing natural or artificial or dermal matrix with or without silk fibers in order to provide complete occlusion also provide additional advantages to the system.
  • the present invention occluder device (1 ) has been made of wires prepared from the nitinol alloy, which is a nickel-titanium alloy known as memory material, or made of a memory polymeric material.
  • the occluder device (1 ) mainly consists of memory wire ball (1.1), the proximal retention zone (1.2), neck zone (1.3), distal retention zone (1.4), the connection apparatus (1.5), the silk fiber (1.6) inside the memory wire ball (1.1 ), natural or artificial acellular dermal matrix (1.7), and dermal matrix fixing seams (1.8).
  • the transport device (2) is a system which carries the occluder device (1) through the groin vessels up to the place where it will be applied with transcatheter method.
  • the transport apparatus (2) is mainly made up of the sheath (2.1 ), the spiral wire carrier (2.2), and the holder apparatus for the spiral wire carrier (2.3).
  • the occluder devices (1) While the occluder devices (1) perform their duties, they are required not to harm the human body. The concern is that the metal ions released from inserted implants may lead to some troubles in later years. Therefore, the design of the lighter occluder devices (1) has been dealt with. Our invention is one of the lightest occluder devices that have ever been developed. This feature is important since especially the nickel ions in nitinol alloy can be detrimental to the human body, so the lightest ones should be preferred if there is no other choice but a device should be placed.
  • the occluder device (1 ) can be obtained by manually winding nitinol wire on a simple mold in a particular pattern, and it attains flexibility and memory property after heat treatment. Its special design like an uncovered basket makes it possible to wind easily.
  • Our invention is one of the lightest occluder devices that have ever been developed with its light metal load; that is, although the proximal retention zone (1 .2) has a disc-shaped volume, the center of the distal retention zone (1 .4) is open. It has been designed like basket and looks as if it is an outspread hem of a whirling dervish, and that is why it is lighter than its counterparts. Wing
  • Another method developed to prevent the release of especially nickel ions into the blood and tissues in time is to coat the device with metal like gold or polymeric material by using various methods. This thin layer prevents corrosion of the device and the release of metal and also provides a faster recovery.
  • the wings of the proximal retention zone (1 .2) and of the distal retention zone (1 .3) are in close proximity to the heart valves and the heart conduction pathway and thus the wings damages the heart valves and heart conduction pathway.
  • the edge of the device (1 ) has been designed semi-circular or oval.
  • when viewed from the side it represents an asymmetric and radial structure.
  • Our occluder device (1 ) contains at least one marker (1 .9) to help cardiologists to see whether it has been located in the right place and in the right position.
  • the position of asymmetric and radius retention zone of the occluder device (1 ) can be monitored more appropriately through X-ray fluoroscopy.
  • Left atrial appendage is in the form of a glove finger and has a curved structure.
  • the device that will occlude this zone consists of proximal, neck and distal parts, the front and back sides of the wire mesh winding has been designed as curved outwardly in the form of tabs so that it can cling to the folds of the appendix and cannot come off.
  • Silk fibers, natural or artificial acellular dermal matrix have been placed into this device also.
  • the structural properties of the occluder device used for the closure of the left atrial appendage mouth or for filling interior of the appendix, should depend on whether the anatomical features of the appendix mouth is narrow, long or wide.
  • narrow-long and flexible devices should be used in the patient. If the appendage is wide-mouthed, then wide and a little harder devices (B) designed for wide-mouthed appendix should be preferred. Whether the devices are rigid or slightly flexible is related to the thickness of the wire they are made of, and if it is made from thinner wire, the device becomes more flexible, and the device becomes more rigid if it is made of thicker wire.
  • the surfaces of the proximal retention area (1 .2) facing the left atrium has been coated with biocompatible and anti-fibrin material so that new thrombus formation, due to the nickel-titanium alloy content of the sides of the occluder device used for the occlusion of the mouth of the left atrial appendage, is prevented.
  • Acellular dermal allograft is a genuine human skin donation obtained from human. It is a natural material derived from undamaged dermal tissue matrix. This material has great advantages for both surgeons and patients. The vital components of this material have been removed and the material has been made acellular in order to prevent immune/infection response and tissue rejection. Physically, it is extremely soft, however, it is resistant to stresses and flexion, and is easy to shape. With the advances in recent years, it is now possible to make physical "artificial dermal matrix" or “artificial scaffold” in the desired form with the method of "three- dimensional tissue scaffold system". Three-dimensional dermal tissue scaffold or matrix is manufactured with specific bio-compatible polymeric materials using mechatronic systems.
  • this natural or artificial dermal matrix When the device is released in patient, this natural or artificial dermal matrix will be opened when the occluder device is opened, and total occlusion will be achieved with the blood-proofing property of the matrix. It is also expected that endocardial surface of the heart or endothelial layer of the blood vessels will coat the device much faster.
  • One of the other features of the occluder devices is that they are required to be designed in various sizes from small to large so that their proximal and distal retention zones and neck regions can be applied in all sizes of defects and in patients of all ages.
  • the manufacture of the device should be planned in all sizes from the narrowest defect (2 mm) up to the largest defect.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Prostheses (AREA)

Abstract

The invention is about an occluder device which is used for treatment through transcatheter in order to occlude congenital heart defects, vascular abnormalities or left atrial appendage and about production process of the device. The device contains biocompatible wire cage made of either a memory metal, or an alloy, or a polymeric material. The device also contains a thread mesh retained to the wire cage and an artificial or natural acellular dermal matrix. The distal retention zone is designed as a hollow "whirling dervish's skirt", and can be circular, oval, triangular according to the type of defect it will occlude. The device may comprise a marker. This special designed device is lighter, and has lower metal loadings than its counterparts. The production process is simpler, and the dermal matrix it contains enables a faster recovery and high complete occlusion success rate. The devices for occluding the left atrial appendage have been designed for narrow or broad defects, and the surfaces of the proximal retention area facing the left atrium has been coated with biocompatible and antifibrin material so that its nickel-titanium alloy content cannot lead to new thrombus formation.

Description

DESCRIPTION
THE OCCLUDER DEVICE FOR CARDIOVASCULAR SYSTEM
TECHNICAL FIELD
The invention is related to the "occluder device" for cardiovascular system and its production process. The occluder device is self-expanding, comprising of braided wire mesh made of a memory material similar to nitinol (nickel-titanium), alloy or metal, thread mesh, natural or artificial matrix. The exterior of the braided wire mesh has been coated with biocompatible material such as gold through various technological methods in order to prevent the secretion and releasing of nickel into the tissues in time, which may be harmful to the human body. The final shape of the device with a hollow design is formed with heat treatment process, and it gains self- expandability. The device consists of an expandable body part which occludes with a partly hollow holder. The body part consists of the proximal retention zone, neck and distal retention zone parts and it is placed in the patients with its specific carrier apparatus.
PRIOR ART
As it is known, defects in the heart due to congenital heart diseases in children or due to abnormal blood vessels outside the heart which are normally supposed to be covered but have not been covered may be present. This type of heart and vascular diseases can be seen in adults but not as common as in children.
For the closure of these defects in cardiovascular system, lumen occlusion devices in different shapes and structures have been used since the past. These devices can be placed by transcatheter methods which require no surgical intervention. Especially in the last ten years, we can see the rapid development in this area. The most common types have been manufactured from nitinol like metal alloy wires known as memory metal. Such devices include a releasable connection apparatus after it has been inserted into appropriate places via the catheter. Also it has a carrier system such that the device can be pulled back into the sheath if the location is not suitable and then can be taken out again.
One of the first examples is the "Amplatzer" branded occluder device of Aga Medical Corporation, and it had two separate welding points; one in the front and one at the back of the lumen occluder device, and all the wires made of nitinol alloy, which establishes the system, were connected together by these two points welding. Then the "Occlutech" branded occluder device that belongs to Occlutech Holding AG was available at the market. Although this device was made of wires with the same alloy and similar design, all the wires were attached together with only one point welding. Thus a lighter device was obtained with only one point welding, and when compared with the other devices, it is stated that less metal load has been imposed to the human body. In following-years, generally the shape of the device or connection apparatus were modified but nitinol, a memory metal, was used in all of them. Screw was used as a connector apparatus in the first twos, and different mechanical apparatus were proposed for the devices developed later.
Nowadays, there is valid rule applies to all implants made of nitinol alloy as it applies to all other metal alloys, and this rule is; unnecessary metal load should not be installed into the human body, if there is no other resort but the implant placement, then the lightest should be preferred. Because metal ions are gradually released from the implant over the years and this can lead to some complications.
BRIEF DESCRIPTION OF THE INVENTIO
The hole in interatrial septum between the two atria of the heart is called "atrial septal defect" and if it is too small, it is called "patent foramen ovale". The hole in the interventricular septum between the two ventricles of the heart is known as "ventricular septal defect". In addition, "patent ductus arteriosus" is another defect to be occluded. Furthermore in order to prevent thrombus build-up in the left atrial appendage in the elderly patients with heart diseases, "occluder device for left atrial appendage" is placed. Thus, surgical intervention of a cardiac surgeon is no longer required for the closure of such defects. Lumen occlusion devices in different shapes and structures are placed by transcatheter methods and occlusion is achieved through the sheath positioned in the groin artery and conveying systems. Occlusion devices known as memory metal wires are made from metal alloys like nitinol. In general, the shape or connection apparatus have been modified in all of the devices but nitinol, which is a memory metal, is still used. Screws are used as the connection apparatus in some devices, but various mechanical apparatus have been proposed in the devices developed later. Nobody knows what problems the metal ions released from the inserted implant will lead to in the years ahead, and at this respect, our invention is one of the lightest metal load occluder devices that have ever been developed, and that is, although the proximal retention zone forms a disc-shaped body, the center of distal retention area is open. It has been designed like basket and looks as if it is an outspread hem of a whirling dervish's skirt, and thus, it has formed a lighter structure than its counterparts. Employing natural or artificial or dermal matrix with or without silk fibers in order to provide complete occlusion also provide additional advantages to the system.
LIST OF FIGURES
Figure 1. Four-Hollow Section of the Heart, and the View of the Occluder Device from its Location
Figure 2. The View of the Occluder Device Used in the Atrial Septal Defect Closure Figure 3. The View of the Occluder Device Used in Patent Foramen Ovale Closure Figure 4. The View of the Occluder Device Used in Ventricular Septal Defect Closure Device
Figure 5. The Lateral Sectional View of the Device Used in Perimembraneous Ventricular Septal Defect Closure
Figure 6. The Anterior Sectional View of the Device Used in Perimembraneous Ventricular Septal Defect Closure
Figure 7. The Superior Radius Sectional View of the Device Used in Perimembraneous Ventricular Septal Defect Closure
Figure 8. The View of the Device Used in the Patent Ductus Arteriosus Closure Figure 9. The View of the Occluder Device Used in Vessels
Figure 10.The View of the Conical Shaped Occluder Device Used in Patent Ductus
Arteriosus Closure
Figure 11. Manufacturing Process
Figure 12. Whirling Dervish
Figure 13. Natural or Artificial Dermal Matrix and Fixing Seams
Figure 14. The View of the Occluder Device Used in Left Atrial Appendage
Closure, (A: for narrow and long appendage B: for wide-mouthed appendage) Provision of the track numbers specified in the figures is given below.
1. Occluder Device
1.1. Memory Wire Ball
1.2. Proximal Retention Area
1.3. Neck Area
1.4. Distal Retention Area
1 .5. Connection Apparatus
1.6. Silk Fiber
1.7. Natural or Artificial Dermal Matrix
1.8. Dermal Matrix Fixing Seams
1.9. Marker
2. Transport Apparatus
2.1. Sheath
2.2. Spiral Wire Carrier
2.3. Holder Apparatus for the Spiral Wire Carrier
DETAILED DESCRIPTION OF THE INVENTION
The present invention occluder device (1 ) has been made of wires prepared from the nitinol alloy, which is a nickel-titanium alloy known as memory material, or made of a memory polymeric material. The occluder device (1 ) mainly consists of memory wire ball (1.1), the proximal retention zone (1.2), neck zone (1.3), distal retention zone (1.4), the connection apparatus (1.5), the silk fiber (1.6) inside the memory wire ball (1.1 ), natural or artificial acellular dermal matrix (1.7), and dermal matrix fixing seams (1.8).
The transport device (2) is a system which carries the occluder device (1) through the groin vessels up to the place where it will be applied with transcatheter method. The transport apparatus (2) is mainly made up of the sheath (2.1 ), the spiral wire carrier (2.2), and the holder apparatus for the spiral wire carrier (2.3).
While the occluder devices (1) perform their duties, they are required not to harm the human body. The concern is that the metal ions released from inserted implants may lead to some troubles in later years. Therefore, the design of the lighter occluder devices (1) has been dealt with. Our invention is one of the lightest occluder devices that have ever been developed. This feature is important since especially the nickel ions in nitinol alloy can be detrimental to the human body, so the lightest ones should be preferred if there is no other choice but a device should be placed.
The occluder device (1 ) can be obtained by manually winding nitinol wire on a simple mold in a particular pattern, and it attains flexibility and memory property after heat treatment. Its special design like an uncovered basket makes it possible to wind easily.
Our invention is one of the lightest occluder devices that have ever been developed with its light metal load; that is, although the proximal retention zone (1 .2) has a disc-shaped volume, the center of the distal retention zone (1 .4) is open. It has been designed like basket and looks as if it is an outspread hem of a whirling dervish, and that is why it is lighter than its counterparts. Wing
Additional benefits are provided to the system by way of employing natural or artificial dermal matrix (1 .7) instead of silk fibers for assuring complete blockage.
Another method developed to prevent the release of especially nickel ions into the blood and tissues in time is to coat the device with metal like gold or polymeric material by using various methods. This thin layer prevents corrosion of the device and the release of metal and also provides a faster recovery.
One of the important problems encountered especially during the perimembranous ventricular septal defect occlusion is that the wings of the proximal retention zone (1 .2) and of the distal retention zone (1 .3) are in close proximity to the heart valves and the heart conduction pathway and thus the wings damages the heart valves and heart conduction pathway. As a solution to this problem, the edge of the device (1 ) has been designed semi-circular or oval. In addition, when viewed from the side it represents an asymmetric and radial structure. Thus, during the perimembranous ventricular septal defect occlusion, it enables the occluder device (1 ) to locate into the defect completely.
Our occluder device (1 ) contains at least one marker (1 .9) to help cardiologists to see whether it has been located in the right place and in the right position. Thus, especially during occlusion of perimembranous ventricular septal defect, the position of asymmetric and radius retention zone of the occluder device (1 ) can be monitored more appropriately through X-ray fluoroscopy.
Left atrial appendage is in the form of a glove finger and has a curved structure. Although the device that will occlude this zone consists of proximal, neck and distal parts, the front and back sides of the wire mesh winding has been designed as curved outwardly in the form of tabs so that it can cling to the folds of the appendix and cannot come off. Silk fibers, natural or artificial acellular dermal matrix have been placed into this device also. The structural properties of the occluder device used for the closure of the left atrial appendage mouth or for filling interior of the appendix, should depend on whether the anatomical features of the appendix mouth is narrow, long or wide. If a narrow-mouthed long appendix view has been obtained through different imaging methods, narrow-long and flexible devices (A) should be used in the patient. If the appendage is wide-mouthed, then wide and a little harder devices (B) designed for wide-mouthed appendix should be preferred. Whether the devices are rigid or slightly flexible is related to the thickness of the wire they are made of, and if it is made from thinner wire, the device becomes more flexible, and the device becomes more rigid if it is made of thicker wire. The surfaces of the proximal retention area (1 .2) facing the left atrium has been coated with biocompatible and anti-fibrin material so that new thrombus formation, due to the nickel-titanium alloy content of the sides of the occluder device used for the occlusion of the mouth of the left atrial appendage, is prevented.
Acellular dermal allograft is a genuine human skin donation obtained from human. It is a natural material derived from undamaged dermal tissue matrix. This material has great advantages for both surgeons and patients. The vital components of this material have been removed and the material has been made acellular in order to prevent immune/infection response and tissue rejection. Physically, it is extremely soft, however, it is resistant to stresses and flexion, and is easy to shape. With the advances in recent years, it is now possible to make physical "artificial dermal matrix" or "artificial scaffold" in the desired form with the method of "three- dimensional tissue scaffold system". Three-dimensional dermal tissue scaffold or matrix is manufactured with specific bio-compatible polymeric materials using mechatronic systems. The recent manufacture of these new natural or artificial matrixes has brought major benefits to our invention. Since they do not include any cells or cell fragments, they do not cause allergic or immunologic reactions, and they are not rejected by the body, and they play an important role in the realization of a complete occlusion, and they also accelerate endothelialization after the process. Moreover, the natural matrix is organized in time among the healthy tissues, and the artificial matrix developed from biocompatible polymer dissolves over time and disappears in the body.
As to the advantages of these developments associated with our invention; as known it has been intended to achieve a complete occlusion quickly through the clinging of the blood platelets on the silk fiber inserted into the occluder device. Thus, blood fibrin fibers together with platelets will prevent possible blood leakage through the biocompatible memory wire like nitinol. When the natural or artificial acellular dermal matrix is placed instead of silk fiber and these are fixed to the nitinol wire, this structuring will provide an additional biomechanical force to the device. As they are soft and can be shaped easily, they can be loaded into the transport system of the device together with the device itself without causing any additional resistance. When the device is released in patient, this natural or artificial dermal matrix will be opened when the occluder device is opened, and total occlusion will be achieved with the blood-proofing property of the matrix. It is also expected that endocardial surface of the heart or endothelial layer of the blood vessels will coat the device much faster.
One of the other features of the occluder devices is that they are required to be designed in various sizes from small to large so that their proximal and distal retention zones and neck regions can be applied in all sizes of defects and in patients of all ages. The manufacture of the device should be planned in all sizes from the narrowest defect (2 mm) up to the largest defect.

Claims

C L A I M S
1. It is the occluder device (1 ) used with transcatheter in patients with congenital heart defects, vascular abnormalities such as patent ductus arteriosus or with left atrial appendage thrombus, and its properties are characterized in that it consists of the memory wire ball (1 .1 ) , the proximal retention zone (1 .2), neck area (1 .3), distal retention area (1.4), the connection apparatus (1 .5) , the silk fiber (1 .6) in the memory wire ball (1 .1 ), acellular natural or artificial dermal matrix (1 .7), dermal matrix fixing seams (1 .8) parts.
2. It is the occluder device (1 ) mentioned in Claim 1 , and it is characterized in that circular or oval artificially prepared dermal matrix has been fixed into the proximal retention regions of the device.
3. It is the occluder device (1 ) mentioned in Claim 1 , and it is characterized in that although its proximal retention zone constitutes a disk shaped volume, the center of the distal retention zone is like a basket and an outspread hem of a whirling dervish's skirt.
4. It is the occluder device (1 ) mentioned in Claim 1 , and it is characterized in that the wire mesh comprising proximal retention zone (1 .2), neck area (1 .3) and distal retention zone (1 .4) has been fixed altogether with a connector apparatus (1 .5) through single point welding.
5. It is the occluder device (1 ) mentioned in Claim 1 , and it is characterized in that when it is released in the defect, it can position itself by self-centering.
6. It is the edge of the distal retention zones (1.3) mentioned in Claim 1 , and it is characterized in that the end of the edge has at least one marker (1.9) for assisting the placement of the device in the correct position.
7. It is the occluder device (1 ) mentioned in Claim 1 , and it is characterized in that it has been coated with a material like gold or a polymeric material.
8. It is the memory wire ball (1.1) mentioned in Claim 1 , and it is characterized in that it consists of at least one wire and at least one mesh which is attached to the wires and made of silk fiber.
It is the memory wire ball (1.1) mentioned in Claim 1 , and it is characterized in that it is the part that provides a complete occlusion in the atrial septal defect when it is placed between the left and right atrium of the heart.
10. They are the proximal retention zone (1.2), neck area (1.3), distal retention area (1 .4) mentioned in Claim 1 , and they are characterized in that their sections have special designs including geometric shapes such as round, oval, semicircular or triangular shapes.
11. It is the proximal retention zone (1.2) mentioned in Claim 1 , and it is characterized in that it consists of at least one wire and at least one thread mesh, and it is the part that provides a complete occlusion in the ventricular septal defect when it is placed between the left and right ventricles of the heart.
12. It is the proximal retention zone (1.2) mentioned in Claim 1 , and it is characterized in that it has been designed asymmetric to prevent the device from damaging the heart valves during the occlusion of the perimembraneous defects located very close to the heart valves in ventricular septum.
13. It is the proximal retention zone (1.2) mentioned in Claim 1 , and it is characterized in that it is the special designed part which enables to occlude the subarterial (subaortic and/or subpulmonic) localized defects without damaging the valves.
14. It is the neck zone (1.3) mentioned in Claim 1 , and it is characterized in that it consists of at least one wire and at least one thread mesh, and it provides complete occlusion on the open ductus arteriosus when it is positioned between the left and right atrium of the heart.
15. It is the device (1 ) to be used for narrow and long appendixes mentioned in Claim 1 , and it is characterized in that it is made of flexible and thin wires, and has a narrow-long structure.
16. It is the device (1 ) to be used for wide and short appendixes mentioned in Claim 1 , and it is characterized in that it is made of rigid and thick wires, and it has a wider structure.
17. It is the device (1 ) that occludes the left atrial appendage mentioned in Claim 1 , and it is characterized in that the wire mesh winding has been designed as curved outwardly in the form of tabs so that it can hold tightly on the left atrial appendage, which has a glove finger -shaped and folded structure, and cannot come off.
18. It is the occluder device (1 ) mentioned in Claim 1 , and it is characterized in that in order to prevent new thrombus formation due to the nickel-titanium (nitinol) alloy of the device which occludes the left atrial appendage, the surfaces of the proximal retention area (1.2) facing the left atrium has been coated with biocompatible and anti-fibrin material.
19. It is the occluder device (1 ) mentioned in Claim 1 , and it is characterized in that its proximal and distal retention zones and neck regions are in various sizes so that it can be applied in the all sizes of defects and patients of all ages.
PCT/TR2014/000234 2013-07-02 2014-06-30 The occluder device for cardiovascular system WO2015002625A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2013/07933 2013-07-02
TR201307933 2013-07-02

Publications (1)

Publication Number Publication Date
WO2015002625A1 true WO2015002625A1 (en) 2015-01-08

Family

ID=51453830

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2014/000234 WO2015002625A1 (en) 2013-07-02 2014-06-30 The occluder device for cardiovascular system

Country Status (1)

Country Link
WO (1) WO2015002625A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107233115A (en) * 2016-03-28 2017-10-10 上海微创医疗器械（集团）有限公司 Occluder for left auricle
WO2018219151A1 (en) * 2017-06-02 2018-12-06 上海微创医疗器械（集团）有限公司 Medical apparatus
WO2019075640A1 (en) * 2017-10-17 2019-04-25 上海微创医疗器械（集团）有限公司 Left atrial appendage occlusion device and left atrial appendage occlusion system
CN114559642A (en) * 2022-02-28 2022-05-31 上海形状记忆合金材料有限公司 Preparation method and preparation device for closing end of plugging device
WO2022127359A1 (en) * 2020-12-17 2022-06-23 先健科技(深圳)有限公司 Delivery device and delivery system

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080249562A1 (en) * 2007-04-05 2008-10-09 Nmt Medical, Inc. Septal closure device with centering mechanism
US20090062841A1 (en) * 2004-03-19 2009-03-05 Aga Medical Corporation Device for occluding vascular defects
WO2009029261A1 (en) * 2007-08-27 2009-03-05 Cook Incorporated Spider pfo closure device
US20120271337A1 (en) * 2007-04-16 2012-10-25 Hans-Reiner Figulla Occluder For Occluding an Atrial Appendage and Production Process Therefor

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090062841A1 (en) * 2004-03-19 2009-03-05 Aga Medical Corporation Device for occluding vascular defects
US20080249562A1 (en) * 2007-04-05 2008-10-09 Nmt Medical, Inc. Septal closure device with centering mechanism
US20120271337A1 (en) * 2007-04-16 2012-10-25 Hans-Reiner Figulla Occluder For Occluding an Atrial Appendage and Production Process Therefor
WO2009029261A1 (en) * 2007-08-27 2009-03-05 Cook Incorporated Spider pfo closure device

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107233115A (en) * 2016-03-28 2017-10-10 上海微创医疗器械（集团）有限公司 Occluder for left auricle
CN107233115B (en) * 2016-03-28 2020-01-24 上海微创医疗器械（集团）有限公司 Left auricle plugging device
WO2018219151A1 (en) * 2017-06-02 2018-12-06 上海微创医疗器械（集团）有限公司 Medical apparatus
WO2019075640A1 (en) * 2017-10-17 2019-04-25 上海微创医疗器械（集团）有限公司 Left atrial appendage occlusion device and left atrial appendage occlusion system
WO2022127359A1 (en) * 2020-12-17 2022-06-23 先健科技(深圳)有限公司 Delivery device and delivery system
CN114559642A (en) * 2022-02-28 2022-05-31 上海形状记忆合金材料有限公司 Preparation method and preparation device for closing end of plugging device

Similar Documents

Publication Publication Date Title
KR101681346B1 (en) Heart occlusion devices
RU2446773C2 (en) Multilayered woven constructions for occlusion of vascular defects
EP2757957B1 (en) Medical implantable occlusion device
US20140005714A1 (en) Multilayered expandable braided devices and methods of use
JP2015501691A (en) Medical occlusion device
EP2387950A1 (en) Medical implant and manufacturing method thereof
CN105054985A (en) Improved left auricle occluder
WO2015002625A1 (en) The occluder device for cardiovascular system
JP2019502521A (en) Decomposable occluder
WO2018145535A1 (en) Occlusion device
CN204814031U (en) Modified left auricle of heart plugging device
RU128101U1 (en) OKCLUDER
CN106691521B (en) Plugging device
EP4358873A2 (en) Systems and methods for treating the left atrial appendage
CN207996221U (en) Degradable heart arter patent ductus plugging device
CN207785224U (en) Degradable heart occluder for left auricle
CN211355676U (en) Patent ductus arteriosus occluder
CN107019530A (en) A kind of across valve device
CN109498073A (en) A kind of safety device for preventing heart implantation instrument from falling off, method and its application
US11103250B2 (en) Aneurysm occluder
CN109381239A (en) A kind of patend ductus arteriosus occluder
KR102389237B1 (en) Multifunctional occlusion device
CN115153723A (en) Degradable heart plugging device for patent arterial duct without riveting points on two sides
US20210361270A1 (en) Multi-functional occluder
CN115153684A (en) Bilateral non-riveted-point patent foramen ovale degradable heart plugging device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14758186

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14758186

Country of ref document: EP

Kind code of ref document: A1